In this article, they talk about some companies and what people think about them. They are trying to decide if these companies are good to buy or sell. Some of the companies mentioned are TransDigm Group, Sonos, Thermo Fisher Scientific and a tech company. These people watch how these companies do in the stock market and give their opinions on TV show called CNBC's "Final Trades". Read from source...

- The title is misleading and vague, it does not specify which tech company was featured on CNBC's "Final Trades", making the reader wonder what they missed out on.
- The article does not provide any context or background information about TransDigm Group, West Pharmaceutical, Thermo Fisher Scientific, or the unnamed tech company, which are all prominent and diverse companies in different industries. This makes it hard for the reader to understand their relevance and significance to the topic of the article.
- The article relies on opinions from Steve Weiss and Brian Belski, who are not well-known experts or analysts in the field, and whose credibility and track record are not established or verified by any sources or data. This makes their picks and recommendations less reliable and trustworthy for the reader.
- The article does not mention any potential risks, challenges, or drawbacks associated with investing in any of the companies mentioned, which could affect their performance and profitability in the future. This creates a biased and optimistic view of the market and the companies, without considering the possibility of losses or disappointments for the reader.
- The article does not provide any evidence or analysis to support the claims made by Steve Weiss and Brian Belski, such as why they chose these specific companies, what factors influenced their decisions, how they expect them to perform in the short and long term, etc. This leaves the reader with no insight or understanding of the logic behind their picks and recommendations.

To provide you with comprehensive investment recommendations based on the article titled "TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'," I will first summarize the main points of each company and their respective earnings expectations. Then, I will evaluate the risks and potential rewards associated with investing in these companies based on various factors such as market trends, valuation, growth prospects, and technical analysis. Finally, I will rank the companies according to my criteria and provide a brief rationale for each ranking.